EI
GH icon

EAM Investors’s Guardant Health GH Stock Holding History

EAM Investors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-71,074
Closed -$7.26M – 311
2025
Q4 		$7.26M Sell
71,074
-1,421
-2% -$127K 0.81% 8
2025
Q3 		$4.46M Buy
+72,495
New +$3.94M 0.51% 85
2025
Q2 		– Sell
-107,896
Closed -$4.6M – 284
2025
Q1 		$4.6M Buy
+107,896
New +$4.66M 0.79% 19
2019
Q3 		– Sell
-14,996
Closed -$1.29M – 262
2019
Q2 		$1.29M Sell
14,996
-1,380
-8% -$105K 0.32% 149
2019
Q1 		$1.26M Sell
16,376
-22,445
-58% -$1.24M 0.31% 150
2018
Q4 		$1.46M Buy
+38,821
New +$1.43M 0.4% 115

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM Investors's GH Position: Q1 2026 in Review

EAM Investors sold out of Guardant Health (GH) in Q1 2026, closing a stake of 71,074 shares — an estimated $7.26M sold.

EAM Investors first reported a position in GH in Q4 2018 and held it in 6 quarters. The position peaked at $7.26M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • EAM Investors reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • EAM Investors sold 71,074 Guardant Health shares in Q1 2026, an estimated $7.26M.
  • EAM Investors first reported a position in Guardant Health in Q4 2018 and held it in 6 quarters.
  • EAM Investors's Guardant Health position peaked at $7.26M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.